Cargando…

Economic Burden of Schizophrenia in South Korea

This study estimates the treated prevalence of schizophrenia and the annual costs associated with the illness in Korea in 2005, from a societal perspective. Annual direct healthcare costs associated with schizophrenia were estimated from National Health Insurance and Medical Aid records. Annual dire...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Sung Man, Cho, Seong-Jin, Jeon, Hong Jin, Hahm, Bong-Jin, Lee, Hyo Jung, Park, Jong-Ik, Cho, Maeng Je
Formato: Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2526443/
https://www.ncbi.nlm.nih.gov/pubmed/18436996
http://dx.doi.org/10.3346/jkms.2008.23.2.167
_version_ 1782158758642712576
author Chang, Sung Man
Cho, Seong-Jin
Jeon, Hong Jin
Hahm, Bong-Jin
Lee, Hyo Jung
Park, Jong-Ik
Cho, Maeng Je
author_facet Chang, Sung Man
Cho, Seong-Jin
Jeon, Hong Jin
Hahm, Bong-Jin
Lee, Hyo Jung
Park, Jong-Ik
Cho, Maeng Je
author_sort Chang, Sung Man
collection PubMed
description This study estimates the treated prevalence of schizophrenia and the annual costs associated with the illness in Korea in 2005, from a societal perspective. Annual direct healthcare costs associated with schizophrenia were estimated from National Health Insurance and Medical Aid records. Annual direct non-healthcare costs were estimated for incarceration, transport, community mental health centers, and institutions related to schizophrenia. Annual indirect costs were estimated for the following components of productivity loss due to illness: unemployment, reduced productivity, premature mortality, and caregivers' productivity loss using a human capital approach based on market wages. All costs were adjusted to 2005 levels using the healthcare component of the Consumer Price Index. The treated prevalence of schizophrenia in 2005 was 0.4% of the Korean population. The overall cost of schizophrenia was estimated to be $ 3,174.8 million (3,251.0 billion Won), which included a direct healthcare cost of $ 418.7 million (428.6 billion Won). Total direct non-healthcare costs were estimated to be $ 121 million (123.9 billion Won), and total indirect costs were estimated at $ 2,635.1 million (2,698.3 billion Won). Unemployment was identified as the largest component of overall cost. These findings demonstrate that schizophrenia is not rare, and that represents a substantial economic burden.
format Text
id pubmed-2526443
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher The Korean Academy of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-25264432008-11-06 Economic Burden of Schizophrenia in South Korea Chang, Sung Man Cho, Seong-Jin Jeon, Hong Jin Hahm, Bong-Jin Lee, Hyo Jung Park, Jong-Ik Cho, Maeng Je J Korean Med Sci Original Article This study estimates the treated prevalence of schizophrenia and the annual costs associated with the illness in Korea in 2005, from a societal perspective. Annual direct healthcare costs associated with schizophrenia were estimated from National Health Insurance and Medical Aid records. Annual direct non-healthcare costs were estimated for incarceration, transport, community mental health centers, and institutions related to schizophrenia. Annual indirect costs were estimated for the following components of productivity loss due to illness: unemployment, reduced productivity, premature mortality, and caregivers' productivity loss using a human capital approach based on market wages. All costs were adjusted to 2005 levels using the healthcare component of the Consumer Price Index. The treated prevalence of schizophrenia in 2005 was 0.4% of the Korean population. The overall cost of schizophrenia was estimated to be $ 3,174.8 million (3,251.0 billion Won), which included a direct healthcare cost of $ 418.7 million (428.6 billion Won). Total direct non-healthcare costs were estimated to be $ 121 million (123.9 billion Won), and total indirect costs were estimated at $ 2,635.1 million (2,698.3 billion Won). Unemployment was identified as the largest component of overall cost. These findings demonstrate that schizophrenia is not rare, and that represents a substantial economic burden. The Korean Academy of Medical Sciences 2008-04 2008-04-20 /pmc/articles/PMC2526443/ /pubmed/18436996 http://dx.doi.org/10.3346/jkms.2008.23.2.167 Text en Copyright © 2008 The Korean Academy of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Chang, Sung Man
Cho, Seong-Jin
Jeon, Hong Jin
Hahm, Bong-Jin
Lee, Hyo Jung
Park, Jong-Ik
Cho, Maeng Je
Economic Burden of Schizophrenia in South Korea
title Economic Burden of Schizophrenia in South Korea
title_full Economic Burden of Schizophrenia in South Korea
title_fullStr Economic Burden of Schizophrenia in South Korea
title_full_unstemmed Economic Burden of Schizophrenia in South Korea
title_short Economic Burden of Schizophrenia in South Korea
title_sort economic burden of schizophrenia in south korea
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2526443/
https://www.ncbi.nlm.nih.gov/pubmed/18436996
http://dx.doi.org/10.3346/jkms.2008.23.2.167
work_keys_str_mv AT changsungman economicburdenofschizophreniainsouthkorea
AT choseongjin economicburdenofschizophreniainsouthkorea
AT jeonhongjin economicburdenofschizophreniainsouthkorea
AT hahmbongjin economicburdenofschizophreniainsouthkorea
AT leehyojung economicburdenofschizophreniainsouthkorea
AT parkjongik economicburdenofschizophreniainsouthkorea
AT chomaengje economicburdenofschizophreniainsouthkorea